Ibutilide

Ibutilide is a Class III antiarrhythmic agent available exclusively for intravenous administration.

Indications

  • It is indicated for use in the hospital setting for the cardioversion of recent-onset atrial fibrillation or atrial flutter. Pharmacological cardioversion (alternatively referred to as "chemical cardioversion") may be performed as an alternative to electrical cardioversion to restore normal sinus rhythm. However, the rate of sinus rhythm restoration appears to be lower with pharmacological cardioversion.
  • In highly refractory cases, even during electrical cardioversion of atrial fibrillation, it may be utilized adjunctively to electrical cardioversion to facilitate the restoration of normal sinus rhythm.

Adverse Effects

  • As a Class III agent, ibutilide can significantly prolong the QT interval and induce polymorphic ventricular tachycardia, specifically Torsades de Pointes. Consequently, any patient undergoing pharmacological cardioversion for atrial fibrillation or atrial flutter must be monitored for several hours, typically up to 4–6 hours, within the hospital. This continuous monitoring is required until the drug is cleared and the risk of this highly malignant arrhythmia is eliminated.

The highly life-threatening Torsades de Pointes tachycardia

2026-11-18T22:39:28+00:00